BTIG Maintains Buy on Globus Medical, Raises Price Target to $78

Benzinga · 10/14 16:51
BTIG analyst Ryan Zimmerman maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $77 to $78.